A Comparative Study Between Ultrasound Guided Shoulder Block and Pericapsular Nerve Group Bock for Shoulder Arthroscopic Surgeries: Double Blinded Randomized Clinical Trial

Sponsor
General Committee of Teaching Hospitals and Institutes, Egypt (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05982951
Collaborator
(none)
50
2
7

Study Details

Study Description

Brief Summary

Shoulder arthroscopic surgeries are one of the most common procedures performed on a daily basis in our practice. The arthroscopic techniques offer a lesser invasive option as Open repair does not offer a significantly better 2-year result in terms of stability, and furthermore, can negatively affect the recovery of the full range of motion of the shoulder. Open techniques Shoulder procedures are performed arthroscopically nowadays with fewer complications compared with open surgery.

Indications of shoulder arthroscopy are expanding and include biceps tears, labral tears, rotator muscles tears, subacromial impingements chondral injuries, loose bodies, early degenerative changes, adhesive capsulitis, shoulder instability and acromioclavicular osteoarthritis.

There are many regional anesthetic techniques used to control perioperative pain during arthroscopic procedures. Interscalene block results in effective shoulder surgery analgesia, but it is associated with various complications such as diaphragmatic paralysis due to the high incidence of phrenic nerve block.

The suprascapular nerve block combined with the axillary nerve block is non-inferior to conventional inter-scalene block except for the early recovery period with the advantage of lower incidence of dyspnea and discomfort.

. In a cadaveric anatomical study that the posterosuperior quadrant and the posteroinferior quadrant of the GHJ were innervated by the suprascapular nerve and the axillary nerve respectively. While the anterosuperior quadrant portion of the joint is sensory supplied by the subscapularis superior branch and the anteroinferior by the main branch of the axillary nerve. These anatomical data the possibility of a new block targeting the GHJ sensory branches. It was suggested that deep pericapsular infiltration of local anesthetic towards the subscapularis may cover the axillary and subscapularis branches that feed the anteroinferior and superior quadrants of the GHJ.

Recently, the pericapsular nerve group block of the shoulder joint as described in a case series including two cases underwent a humeral neck fracture fixation and Bankart arthroscopic repair with promising anesthesia and analgesia in selected shoulder surgeries.

Detailed Description

anesthetics Bleeding disorders receiving antiplatelet or anticoagulant drugs local infection at site of local injection Intra articular infections

Sample size and methodology:

WE will enroll 42 patient undergoing elective shoulder arthroscopy. They will be randomized and allocated into two groups; Group A and group B. Group A will receive ultrasound guided PENG block and group B will receive shoulder block Sample size justification Sample size was calculated using Power Analysis and Sample Size software program (PASS) version 11.0.4 for windows (2011) with time to first analgesic request as the primary outcome. Using the results published by Pani et al 2019 (8) with the mean time to first analgesic request in shoulder block group was (5.9 ± 1.2 hours) Using a two-sided two-sample unequal-variance t-test, sample size of 42 patients is needed to achieve 95% power to detect 20 % difference in time to first analgesic request. Using a two-sided hypothesis test with a significance level of 0.05.

Anticipated Results The application of pericapsular nerve group block in patients undergoing elective shoulder arthroscopic surgeries may improve management of their perioperative pain.

Randomization:

The study subjects will be randomized by using block randomization using sealed concealed envelopes into two groups.

Data collection:

The patients will be observed or 24 hours postoperatively by a blinded investigator for the given block. All patients will receive one gram acetaminophen intravenously every 8 hours as apart o multimodal analgesia protocol.

Primary outcome will be the duration of analgesia (time to first rescue analgesia after administration of the block). Postoperative pain will be assessed using 100 mm vertical visual analogue score (VAS). The pain score will be recorded at 0, 1, 4, 8, 12, and 24 hours at rest (VASr) and movement (VASm). Morphine will be given intravenously if VASr, VASm or both exceeds 30mm in one milligram allequate with 5 minutes intervals till VAS be less than 30 mm or exceeding safety dose of 30 mg in 4 hours.

Secondary outcomes:

Total fentanyl consumptions as a rescue analgesia intaoperatively. Total morphine consumption in 24 hours postoperatively. Intraoperative hemodynamics mean arterial pressure and mean heart rate. length of stay in hospital Ability to perform physical rehabilitation program in the first 24 hours postoperatively.

postoperative sedation score using Ramsey score patient satisfaction will be assessed by numerical score (1= very dissatisfied, 2= dissatisfied, 3=neither satisfied or dissatisfied, 4= satisfied, 5=very satisfied) postoperative nausea and vomiting (PONV) will be assessed using four points numerical score (0=no PONV, 1= mild nausea , 2= severe nausea or vomiting once, 3= vomiting more than once)

End point:

The observation of patients will be finished 24 hours posoperatively.

Results:

It will be recorded and analyzed statistically.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
The block will be performed by one investigator who is not participating in either data collection or analysis. Also the patient will be blinded .
Primary Purpose:
Treatment
Official Title:
A Comparative Study Between Ultrasound-guided Shoulder Block and Pericapsular Nerve Group Bock for Shoulder Arthroscopic Surgeries.
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Shoulder PENG block group

Ultrasound-guided peri-capsular nerve block of the shoulder with 20ml of 0.25% bupivacaine between the supraspinatus muscle and deltoid muscle.

Procedure: Shoulder PENG block
Ultrasound guided insertion of a needle between subscapularis tendon and deltoid with injection of 10 mi 0.25% bupivacaine after confirming right plane of injection
Other Names:
  • Shoulder Block
  • Active Comparator: Shoulder block

    ultrasound guided axillary nerve block and suprascapular nerve block posterior approach with 10 ml 0.25% bupivacaine (total 20ml)

    Procedure: Shoulder PENG block
    Ultrasound guided insertion of a needle between subscapularis tendon and deltoid with injection of 10 mi 0.25% bupivacaine after confirming right plane of injection
    Other Names:
  • Shoulder Block
  • Outcome Measures

    Primary Outcome Measures

    1. Duration of analgesia (time to first rescue analgesia) minutes [24 hours after surgery]

      Postoperative pain will be assessed using 100 millimeter vertical visual analog score (VAS) where (1-3) no pain, >3- 6) mild pain, and (>6 severe pain). The pain score will be recorded at 0, 1, 4, 8, 12, and 24 hours at rest (VASr) and movement (VASm). Morphine will be given intravenously if VASr, VASm, or both exceed 30mm in one milligram adequate with 5 minutes intervals till VAS be less than 30 mm or exceeds the safety dose of 30 mg in 4 hours.

    Secondary Outcome Measures

    1. Total morphine consumption milligrams [24 hours after surgery]

      Total morphine consumption in 24 hours postoperatively.

    2. Total fentanyl consumptions microgram [Intraoperative period]

      Total fentanyl consumptions as a rescue analgesia intaoperatively

    3. intraoperative hemodynamics [Intraoperative period]

      Mean arterial blood pressure millimeter mercury , mean heart rate beat per minute

    4. length of stay in hospital hours [24 hours postoperative]

      length of stay in hospital after surgery by hours

    5. postoperative sedation [Immediate postoperative period]

      Ramsey sedation Score

    6. patient satisfaction [24 hours postoperative]

      numerical score (1= very dissatisfied, 2= dissatisfied, 3=neither satisfied or dissatisfied, 4= satisfied, 5=very satisfied)

    7. postoperative nausea and vomiting (PONV) [24 hours postoperative]

      four points numerical score (0=no PONV, 1= mild nausea , 2= severe nausea or vomiting once, 3= vomiting more than once)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • ASA I - II

    • Age between 18 - 60

    • unilateral elective shoulder arthroscopic surgery

    Exclusion Criteria:
    • Patient refusal

    • Altered mental status or un-cooperative patients

    • Hypersensitivity to local anesthetics

    • Bleeding disorders

    • receiving antiplatelet or anticoagulant drugs

    • local infection at the site of local injection

    • Intra articular infections

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • General Committee of Teaching Hospitals and Institutes, Egypt

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Kareem Mikhamer, Fellow lecturer of Anaesthesia, General Committee of Teaching Hospitals and Institutes, Egypt
    ClinicalTrials.gov Identifier:
    NCT05982951
    Other Study ID Numbers:
    • GeneralCTHI
    First Posted:
    Aug 9, 2023
    Last Update Posted:
    Aug 9, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Aug 9, 2023